Pages
- 404
- Case Studies
- Computational Biology
- Cookie Policy
- Data means More
- Data Mesh Services
- Data-Driven Precision
- Documents
- Excelra for AI
- Glossary
- Industry
- New Bioinformatics
- New Home Page
- Precision Medicine
- Sitemap
- Our Distributors
- Data FAIRification
- BioVisualizer – Thank you
- Cheminformatics
- error-403
- Platforms
- Core
- Custom Biomarker Knowledgebase
- Home
- About us
- Careers
- Databases
- Our Services
- Data
- Insights
- Scientific Informatics
- Scientific Applications
- Cloud enablement
- Scientific Data Management
- Lab informatics
- Accelerating drug discovery with seamless global collaboration
- Compound screening platform for drug discovery and design
- Integrated Genomic, Target Assessment, and Clinical DataLake
- LIMS Integration with AI/ML Cheminfomartics Pipelines
- Supporting Last Mile to Eliminate Leprosy Forever!
- Transforming animal health research: The ultimate OMICs data hub
- Unlocking the potential of open targets through research publication browser
- Compound Screening Platform for drug discovery and design
- Transforming Animal Health Research: The Ultimate OMICs Data Hub
- Get in touch
- Request for free demo – GOSTAR™ Large Molecules
- Request for free demo – GOSTAR™ Small Molecules
- Request for free demo – GOSTAR™ TPD
- Newsroom
- Events
- exNeX Boston
- Optimizing Data-Driven Drug Design with AIDDISON™ Software & GOSTAR®
- Join Excelra at Biotech X USA
- Sapiocon 2025
- Bio-IT World Conference & Expo 2025
- BioTechX EU 2025
- BioTechX USA 2025
- Paperless Lab Academy (PLA) USA 2025
- The Festival of Genomics & Biodata 2025
- Drug Discovery Chemistry Conference 2025
- From Clinical Data to Decisions: Integrating Clinical Pharmacology with Pharmacometrics Modelling
- Optimizing Data-Driven Drug Design with GOSTAR™
- Pistoia Alliance Spring London Conference 2025
- Pistoia Alliance USA Conference 2025
- Webinars
- Data means more
- Videos
- Join our team
- Blogs
- Publications
- Whitepapers
- Case Studies old
- Terms of Use
- Privacy Policy
- Pharma & Biotech
- AI/ML
- Academia
- Terms of Use
- Privacy Policy
- ELN & LIMS
- Biomarkers
- AI / ML
- Clinical Pharmacology
- HEOR-RWE
Posts by category
- Category: Bioinformatics
- Category: BioVisualizer
- Category: Blogs
- Transforming Laboratory Synthesis with AI: Automatic Experiment Setup and Data Population
- Data Landscape Asessment: Building the Foundation for Digital Transformation in Pharma
- InnerSource in bioinformatics: Turning analysis into shared understanding
- Unlocking the Value of CRO Data: Best Practices for Standardisation and Seamless Ingestion in Pharma R&D
- AI Agents: Transforming Intelligent Workflows in Life Sciences
- Digitalization in siRNA & Oligo Therapeutics Workflows: Opportunities and Gaps
- Introducing Scaffold Landscape Analysis in GOSTARᵀᴹ TPD
- Overcoming Laboratory Data Chaos (Part 2): Execution, Strategy, and Results
- Overcoming Laboratory Data Chaos (Part 1): The Case for ELN-LIMS Integration
- Why Consulting Firms Need Strategic Scientific Informatics Partners
- Enhancing Lab Efficiency With Revvity Signals
- ELN vs. LIMS: Deciding the Ideal System for Your Organization
- Training your Algorithms: Challenges in Feeding Quality Lab Data to AI
- What Makes U-Net a Winner in Biomedical Image Segmentation Models – Excelra’s take
- Step-by-Step Walkthrough of Targeted Protein Degradation: Understanding the Science and Impact
- 10x Visium: A Breakthrough Enabling Omics Analysis at Spatial Level
- Predicting Caco-2 Permeability of Small Molecule Drugs and Comparing GOSTAR™ to a Benchmarking dataset
- Unlocking New Gen AI Capabilities with Retrieval-Augmented Generation (RAG)
- Leveraging AI in Data Analytics For Precision Medicine
- Achieving Compliance and Meeting Regulatory Standards in Europe: The Role of Data Analytics in the Biotechnology Industry
- Amazon SageMaker Pipelines: Streamlined Troubleshooting and Restarting Failed Pipeline Runs
- Revolutionizing Lipid Nanoparticle Delivery: AI and Data-Driven Approaches
- Modular AI: Enhancing Efficiency and Impact in Life Sciences
- From Instruments to Insights: Revolutionizing Data into Scientific Advancements
- Building Omics Data Assets: Key factors to keep in mind
- Maximize Your ELN/LIMS Investment with Managed Services for Life Sciences
- Lab Informatics Implementation and Delivery
- Biomarker Landscape Analysis: Unveiling Challenges and Opportunities
- Modernize Your Lab: Migration, Integrations, and Custom App Development
- ELN/LIMS Master Data preparation – Building the Foundation for Data Excellence
- Going Digital: Emerging potential of Digital Biomarkers and AI/ML in Healthcare
- Introduction to Continuous Support and Maintenance
- An Introduction to Business Consulting and Scientific Advice in Lab Informatics
- Bioinformatics Solutions: Tools and Techniques for Data-Driven Discoveries
- Unravelling the Path to Drug Discovery through Cheminformatics
- Decoding Life’s Blueprint: The Power of DNA Sequence Analysis in Bioinformatics
- The importance of data visualization in the pharmaceutical industry
- Improving Target Selection & Validation – Role of QSP
- Will Leveraging ELN & LIMS Consultancy Services Improve Efficiency and Precision?
- Exploring New Frontiers: Clinical Pharmacology in Modern Drug Development
- From Clutter to Clarity: The Essential Guide to ELN and LIMS
- Analyzer in GOSTAR: The Drug-Target Interaction Heatmap
- Analyzer in GOSTAR®: Matched Molecular Pair Analysis
- Analyzer in GOSTAR®: Interactive Property Space Exploration
- Types of Drug Discovery Databases
- GOSTAR® Updates: The Latest Feature Enhancements
- 4 major bioinformatics expertise sources for biotech start-ups
- Why should data-driven biotech start-ups opt for a cloud-based computing environment?
- Public data repositories, biobanks or commercial data providers
- How is machine learning changing flow cytometry data analysis?
- Significance of quantitative tools and techniques in reducing drug attrition
- ChEMBL vs. GOSTAR® – Data diversity and compound coverage
- A day in the life of a clinical pharmacology expert
- The role of key opinion leaders in accelerating COVID-19 vaccine use
- Choosing the appropriate ontology management system for your research
- Enhance and expedite drug development decisions with analysis-ready clinical datasets.
- Why you need key opinion leaders (KOLs) in your medical device marketing strategy
- Ontologies and the FAIR data principles
- Using legacy and current data to accelerate drug development
- Semantic metadata catalog for metadata management
- Bringing data to life with KOLs
- The impact of key opinion leaders (KOLs) on the delivery of emerging novel treatments to lung cancer patients
- Repurposed drugs for COVID-19
- Immunostimulation – a key driver to combat coronavirus
- Key aspects of building a predictive analytics engine
- Interview with Anandbir Singh Brar – CEO, Excelra
- Integrated text mining and data curation approaches for biomedical knowledgebase development
- G-protein coupled receptors: structures, research landscape and trends
- GOSTAR®: the largest online medicinal chemistry intelligence database
- GOBIOM’s biomarker database for enabling precision medicine
- GOBIOM – understanding the platform’s utility in clinical research and drug development
- Fairification: a path to scientific data connectivity
- Empowering Drug Discovery with Big Data and Artificial Intelligence
- Drug target dossier: target intelligence for data-driven drug discovery
- Digitization and data science in drug discovery
- Data in healthcare: how far have we come?
- Data-driven drug repurposing
- Data curation for MBMA – an integral part of MID3
- Biologics – the biotech drugs transforming medicine
- Coronavirus clinical trials landscape – analysis using Excelra’s COVID-19 biomarker database
- Life Sciences Tech Trends 2021
- Pivotal role of biomarkers in diagnosing the ever changing landscape of COVID-19 infection
- Category: Clinical Data Services
- Category: Data Science & Analytics
- Category: Data Science & Analytics
- Category: Drug Discovery
- Category: Drug Repurposing
- Category: Featured
- Category: GOSTAR™
- Expanding GOSTAR™ Small Molecules with 1 Million+ New SAR Data Points to Support Data-Driven Drug Design and Optimization
- Expanding GOSTARᵀᴹ TPD with 10K+ New Degraders for Smarter Drug Design and Strategic Decisions
- Excelra and AsedaSciences® announce a strategic Co-Marketing Agreement to provide scientists with single, easy-to-use platform, for small molecule toxicity assessment
- GOSTAR™ SAR Database: Now Faster, Smarter, and More Efficient
- Category: Life Sciences Tech
- Category: Newsroom
- Orogen Therapeutics Partners with Excelra for GOSTAR®
- Excelra certified for third consecutive year – Great Place To Work
- Excelra acquires BISC Global, creating an international bioinformatics powerhouse with an industry-leading platform and service offering
- BISC Global receives half a million euros to develop ML-based suite for accelerated antibody discovery and design
- Excelra partners with Patcore, Inc
- Excelra Partners with HotSpot Therapeutics to Enhance Allosteric Drug Discovery Efforts
- Excelra Makes Strategic Investment in Anlitiks, a Disruptive HEOR and RWE Technology-led Consulting Company
- Excelra Announces Strategic Investment In ProofPilot, a Leading Software as a Service (SaaS) Clinical Trial Research Platform
- X-Chem and Excelra’s GOSTAR® Join Forces to Advance Drug Discovery for Challenging Targets
- XtalPi Partners with Excelra for GOSTAR® to Enhance its Intelligent Digital Drug Discovery and Development Platform
- Silexon Partners with Excelra, Deploying GOSTAR® to Strengthen its AI-driven Drug Discovery and Biopharmaceutical Research Platform
- Excelra Announces Addition of Sudip Nandy to its Board of Directors
- Excelra launches a re-envisioned version of GOSTAR®
- Cyclica to use Excelra’s GOSTAR® Database to develop AI & ML based Deep Learning Algorithm for Drug Target Identification
- Interview with Anandbir Brar, Chief Executive Officer, Excelra | Headline Partner at D4 Global (Virtual Event)
- BISC Global Awarded a Eurostars Grant for the development of a machine learning-based antigen discovery and T-cell epitope prediction software
- BISC Global selected as Top 10 Bioinformatics Company by CIO Applications
- Standigm Partners with Excelra for GOSTAR® to Enhance its AI-Driven Drug Discovery Process
- Excelra Collaborates with Keio University on Drug Repurposing to Explore New Therapeutics for a Rare Indication
- Excelra Announces a Drug Repurposing Collaboration with Maruho on Dermatological Applications
- Excelra and IIT-Kharagpur form strategic partnership to advance Drug Repurposing using NLP & Machine Learning Approaches
- California Institute of Biomedical Research and Excelra Enter into Database Licensing Agreement
- Excelra Earns Acclaim from Frost & Sullivan for its GOBIOM Database, the World’s Largest Repository of Clinical, Pre-Clinical, and Exploratory Biomarkers
- Interview with Dr. Nandu Gattu, Vice President, Pharma Analytics Group at Excelra
- Excelra enters into a Drug Repurposing collaboration with Astellas Pharma
- Excelra expands its Drug Repurposing solutions outreach in Europe through collaboration with H.M. Pharma Consultancy
- Category: Our Thinking
- Category: Publications
- Race-related Host and Microbe Transcriptomic Signatures in Triple-Negative Breast Cancer
- Prevalence and clinical significance of FGFR3 genomic alterations in Asian bladder urothelial carcinoma: A systematic review
- Influence of Dapagliflozin Dosing on Low-Density Lipoprotein Cholesterol in Type 2 Diabetes Mellitus: A Systematic Literature Review and Meta-Analysis
- Decoding the Proboscis Bat Genome: A Genomic Exploration
- Broad proteomics analysis of seeding‑induced aggregation of α‑synuclein in M83 neurons reveals remodeling of proteostasis mechanisms that might contribute to Parkinson’s disease pathogenesis
- Biomarkers – The key to early cancer detection and patient outcomes
- Computational Drug Discovery: Methods and Applications
- Generative Molecular Design and Experimental Validation of Selective Histamine H1 Inhibitors
- Paclitaxel binds and activates C5aR1: A new potential therapeutic target for the prevention of chemotherapy-induced peripheral neuropathy and hypersensitivity reactions
- A Blueprint for High Affinity SARS-CoV-2 Mpro Inhibitors from Activity-Based Compound Library Screening Guided by Analysis of Protein Dynamics
- CODD-Pred: A Web Server for Efficient Target Identification and Bioactivity Prediction of Small Molecules
- Dynamics of the Magnitude, Breadth, and Depth of the Antibody Response at Epitope Level Following Dengue Infection
- Altered DNA methylation in estrogen-responsive repetitive sequences of spermatozoa of infertile men with shortened anogenital distance
- Category: Scientific Informatics
- Category: Lab Informatics
- Category: Uncategorized
- Category: Whitepapers
- The Journey of a Small Molecule: From First Hit to Market
- FAIR Data in Biopharma: An Excelra Perspective
- Data Readiness for AI in Pharma and Biotech
- BioVisualizer™: Enhancing biological data analysis and interpretation
- Accelerating in-vitro antibody discovery with artificial intelligence
- Smoothing the path to drug development with accurate preclinical data
- Power of AI/ML in Medical Imaging: Role in Cancer Diagnosis & treatment
- Omics Data: A Biomedical Asset Driving The Future Of Drug Discovery And Development
- Transforming Unstructured Data into Actionable Insights Using AI
- Spatial Transcriptomics: Decoding Gene Expression Patterns Between Regions Of Interest
- Breaking Barriers: Decoding Innovative Strategies for Functional Proteomics in Drug Discovery and Development
- Identifying Druggable Therapeutic Targets: Unveiling promising avenues in Drug discovery
- Roadmap to Biomarker Discovery: Innovations, Opportunities, and Breakthroughs
- Bridging the gap between biomarker discovery and qualification through a validity index and quantified clinical outcome associations.
- Optimizing scRNA-seq data analysis with effective pipeline development
Portfolio
- From Bottleneck to Breakthrough: Accelerating GSNAP with Fault-Tolerant Mapping
- Cutting the Wait: How FAIR Data and Optimized Workflows Slashed Vaccine R&D Timelines
- Accelerating Small Molecule Discovery with a Cloud-Native Drug Discovery Platform
- Empowering an AI-Driven Future: Unified Data Architecture Accelerates Oncology Research
- Standardizing Oligo Synthesis Workflows with Dotmatics
- Accelerating ASO Drug Discovery with Transparent Machine Learning and Enhanced Off-Target Prediction
- Accelerating Dermatology Innovation Through AI-Driven Drug Repositioning
- Accelerating Microbiome Research and Strain Engineering with Automated Bioinformatics Pipelines
- Strategic Repositioning for Skin Depigmentation in the APAC Market
- Expanding Probiotic Applications in ASD for a Microbiome CRO
- Decoding the Mechanism of Action for a Novel Hair Dye Molecule
- AI-Driven In Silico Screening to Prioritize Flavor Compounds for Olfactory and Gustatory Receptors
- Biomarker Discovery for Cell Line Differentiation
- Scaling Up and Enhancing Efficiency of NGS Pipeline with Nextflow
- Cloud Migration to GCP & Infrastructure Enhancement
- Enhancing Genomic Reference Data Repository
- Novel Scaffold Generation for Herbicidal Compounds
- Toxicity Model Analysis for Fungicide
- Advancing Plant-Insect Interaction Research Through Bioinformatics
- Machine Learning for Predicting Potential Insecticidal Proteins
- Epigenetics in Wheat Genome: Unlocking Gene Regulation Through Advanced Computational Analysis
- RNA-seq analysis of PDX samples
- Tumor Enriched Target Identification
- Data Compendium for MDM2 Inhibitors
- Enabling Cancer Cohort Data Analysis for a Precision Medicine Biotech Company
- Analysis and Design of a Biostatistics Platform
- Bioinformatics Pipeline Development
- Building a Comprehensive Agri Database
- Characterization of Interspecific Introgression
- Centralized OMICs Data Platform for Storage, Cataloguing & Retrieval Across R&D
- Interactive SAR Mining & Visualization Platform for Chemoproteomics-driven Drug Discovery
- Transforming Clinical Diagnostics: Migrating Excel-Based NGS Workflows to a Scalable Web Platform
- Immunoraptor: Transforming Immune Repertoire Analysis
- Scalable Microbiome Data Platform for Advanced Veterinary Research
- Driving Data-Driven Decision Making in Animal Health Through Unified Data Lake Implementation and Visualization
- Human-to-Feline Drug Repurposing: Peptide Redesign for a Novel Veterinary Diabetes Therapy
- Simulation-Led Engineering of Stapled Peptides Against a Pleiotropic Cytokine Receptor
- Designing a Role-Based OMICs Data Lake: Scalable Metadata Architecture for Pharmaceutical R&D
- Building a Scalable Reference Framework for a High-Quality Bat Genome Assembly
- Development of Optimized Workflow for Viral Genome Reconstruction and Taxonomic Classification from RNA-Seq Data
- Request Management System
- Empower Your Data Scientists: Scale Workloads While Reducing Cloud Costs with Excelra
- How the BioVisualizer Platform Accelerates Preclinical Data Analysis
- Advanced Target Profiling in Cancer - A Spatial and Single-Cell Transcriptomics Approach
- Data driven disease-indication expansion and prioritization for specific target inhibitor
- Data-Driven Solutions for Rare Monogenic Blood Disorders: Identifying and Prioritizing Treatment Compounds for Improved Patient Outcomes
- Empowering Client Success: Unveiling the Disease Landscape of Hyperphosphatemia
- Enhancing Vegan Cheese Production: Leveraging Transcriptomic Data for Taste and Texture Improvement
- Personalized Psoriasis Treatment: A Case Study On How AI Accelerated Biomarker Discovery
- A Case Study On Optimizing Immunotherapy with Excelra’s AI-powered Patient Stratification
- Building large Data assets allows MoA elucidation while keeping a view of the competitive landscape
- Accelerating the Development of a Rapid Detection NAAT Assay for SARS-CoV2
- Seamless Data Migration to Benchling: A case study in biotech innovation
- Enterprise Ontologies and Scientific data management: Scibite CENtree with Benchling
- Unveiling the molecular code: Antibody Sequence Mining and Target Affinity Analysis Case Study
- Structuring Investigator’s Brochures
- Structuring preclinical safety reports done in different animal models
- Identification of genomic biomarkers for cell line differentiation
- Leveraging WES data to identify biomarker signatures
- Custom annotation of public single-cell data offers opportunities for target identification
- Fast and cost-effective whole-genome analysis
- Re-analysing database for novel targets
- A robust and high-throughput pipeline for immune repertoire data analysis
- Cloud deployment and integration of university hospital optimised whole-exome pipeline
- Machine Learning: Diagnostic of Prostate Cancer Status
- PK/PD Modeling for Dose Regulation
- Landscape survey of non-small-cell lung carcinoma (NSCLC) for immuno-oncology (IO)
- Development of a hit-calling algorithm on DEL selection data
- Patents are the Cornerstone for Advancing Data-Driven KRAS Drug Discovery
- Modernization and cloud migration of legacy R&D compound registration platform
- Screening adverse events related data
- Building a text-miningbased post-translational modification (PTM) database for SUMOylation
- Ideate, Design and Develop a Gene Visualization Platform
- Case of Dose Regimen Optimization for Paclitaxel
- Data-driven competitive landscape analysis to facilitate Go/No-Go decision in clinical development
- Combination Feasibility Prediction for Checkpoint Inhibitors for a Biologic
- Portfolio Augmentation for a Potential Biologic Drug
- Product Ideation for Pre-filled Syringe Market
- Identification of Predictive Biomarkers and Applications in Patient Enrichment Strategies
- 30 alternate indications identified for six shelved compounds
- Comprehensive Analysis of Putative Drug Targets and their Comparison
- Activity Landscape Analysis for Compound Datasets
- Structured and analysis-ready data for AI/ML-based drug discovery
Glossaries
- Structure–Activity Relationship
- Agentic AI
- Scientific Data Management System (SDMS)
- Electronic Laboratory Notebook (ELN)
- Laboratory Information Management System (LIMS)
- Pharmacogenomics
- Multi-Omics Integration
- Hit to Lead Optimization
- Small Molecule Therapeutics
- Next Generation Sequencing
- Clinical data management
